ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Rauscher Disappointed In CREG Progress

October 1, 1976

Advocacy. Bypass Budget Treated As Serious Funding Request By Advocates

January 30, 1998

NIGMS Awards First Grants For Gene Mapping

August 19, 1988

In Brief: Melanoma Precursors Consensus Conference Planned, DRCC Board Raps Centers Budget Cut

May 20, 1983

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

House Approves NCI’s First $4 Billion Budget, $22.8 Billion For NIH In FY2002.

October 26, 2001